These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21273042)

  • 21. Cancer screening behaviors among Canadian women living with physical disabilities.
    Cooper NS; Yoshida KK
    Arch Phys Med Rehabil; 2007 May; 88(5):597-603. PubMed ID: 17466728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hispanic acculturation and utilization of cervical cancer screening in the US.
    Shah M; Zhu K; Wu H; Potter J
    Prev Med; 2006 Feb; 42(2):146-9. PubMed ID: 16297444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Augmentation of Pap smear screening of high risk aboriginal women. Use of a computerised process tool within the Broome Aboriginal Medical Service.
    Couzos S; Wronski I; Murray R; Cox H
    Aust Fam Physician; 1998 Apr; 27(4):269-74. PubMed ID: 9581335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sociodemographic factors of Pap smear screening in Taiwan.
    Wang PD; Lin RS
    Public Health; 1996 Mar; 110(2):123-7. PubMed ID: 8901257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pap smear screening in a health maintenance organization: 1986-1990.
    Rolnick S; LaFerla JJ; Wehrle D; Trygstad E; Okagaki T
    Prev Med; 1996; 25(2):156-61. PubMed ID: 8860280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reasons women do not attend screening for cervical cancer: a population-based study in Sweden.
    Eaker S; Adami HO; Sparén P
    Prev Med; 2001 Jun; 32(6):482-91. PubMed ID: 11394952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding the role of violence in incarcerated women's cervical cancer screening and history.
    Ramaswamy M; Kelly PJ; Koblitz A; Kimminau KS; Engelman KK
    Women Health; 2011 Jul; 51(5):423-41. PubMed ID: 21797677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pap-smear history of women with invasive cervical squamous carcinoma. A case-control study from Sweden.
    Andersson-Ellström A; Seidal T; Grannas M; Hagmar B
    Acta Obstet Gynecol Scand; 2000 Mar; 79(3):221-6. PubMed ID: 10716304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Women at risk: papanicolaou smear screening in Florida.
    Vincent AL; Greene JN; Hoercherl S; McTague D
    J Fla Med Assoc; 1997; 84(5):302-7. PubMed ID: 9260433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast and cervical cancer screening in Spain and predictors of adherence.
    Martín-López R; Hernández-Barrera V; De Andres AL; Garrido PC; De Miguel AG; García RJ
    Eur J Cancer Prev; 2010 May; 19(3):239-45. PubMed ID: 20110817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breast and cervical cancer screening among Appalachian women.
    Hall HI; Uhler RJ; Coughlin SS; Miller DS
    Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):137-42. PubMed ID: 11815412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Organized cervical cancer screening for underpriviledged women].
    Piana L; Leandri FX; Jacqueme B; Heid P; Corti J; Andrac-Meyer L; Sancho-Garnier H
    Bull Cancer; 2007 May; 94(5):461-7. PubMed ID: 17535784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
    Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
    Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Women's attitudes to and awareness of smear testing and cervical cancer.
    Yu CK; Rymer J
    Br J Fam Plann; 1998 Jan; 23(4):127-33. PubMed ID: 9882766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cervical cancer screening among U.S. women: analyses of the 2000 National Health Interview Survey.
    Hewitt M; Devesa SS; Breen N
    Prev Med; 2004 Aug; 39(2):270-8. PubMed ID: 15226035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cervical cancer screening among Taiwanese women: a transtheoretical approach.
    Tung WC; Lu M; Cook D
    Oncol Nurs Forum; 2010 Jul; 37(4):E288-94. PubMed ID: 20591792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pap test--with or without vaginal smear?
    Milicić-Juhas V; Perić M; Pajtler M; Prvulović I; Curzik D
    Coll Antropol; 2010 Mar; 34(1):69-74. PubMed ID: 20437636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A case-control study of the protective benefit of cervical screening against invasive cervical cancer in NSW women.
    Yang B; Morrell S; Zuo Y; Roder D; Tracey E; Jelfs P
    Cancer Causes Control; 2008 Aug; 19(6):569-76. PubMed ID: 18286380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and cost-effectiveness of nationwide cervical cancer screening in Taiwan.
    Koong SL; Yen AM; Chen TH
    J Med Screen; 2006; 13 Suppl 1():S44-7. PubMed ID: 17227642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.